Literature DB >> 25038602

Serotonin syndrome.

Stefan Alusik1, Dagmar Kalatova2, Zoltan Paluch2.   

Abstract

Serotonin syndrome is a potentially serious clinical condition. In this article, the authors put serotonin syndrome into historical context, discuss its pathophysiology, review in detail its clinical presentations, diagnostic criteria, differential diagnosis and treatment. Special attention is given to drugs that most often cause serotonin syndrome, and the gene polymorphisms involved in the metabolism of these drugs.

Entities:  

Mesh：

Year:  2014        PMID： 25038602

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN： 0172-780X            Impact factor:   0.765


  11 in total

1.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.

Authors:  Serge Gauthier; Howard H Feldman; Lon S Schneider; Gordon K Wilcock; Giovanni B Frisoni; Jiri H Hardlund; Hans J Moebius; Peter Bentham; Karin A Kook; Damon J Wischik; Bjoern O Schelter; Charles S Davis; Roger T Staff; Luc Bracoud; Kohkan Shamsi; John M D Storey; Charles R Harrington; Claude M Wischik
Journal:  Lancet       Date:  2016-11-16       Impact factor: 79.321

2.  PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics.

Authors:  Rachel Huddart; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-06       Impact factor: 2.089

3.  M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Authors:  Azizi Ray; Clinton E Canal; J Christopher Ehlen; Kenner C Rice; Kevin Sean Murnane
Journal:  Neurotoxicology       Date:  2019-06-01       Impact factor: 4.294

4.  Increasing Central Serotonin with 5-hydroxytryptophan Disrupts the Inhibition of Social Gaze in Nonhuman Primates.

Authors:  Hannah B Weinberg-Wolf; Nick Fagan; Olga Dal Monte; Steve W C Chang
Journal:  J Neurosci       Date:  2021-12-03       Impact factor: 6.709

5.  An atypical case of serotonin syndrome with normal dose of selective serotonin inhibitors: A case report.

Authors:  Yun Liu; Hailong Yang; Fei He; Peng Xu; Hanwen Tong; Yao Liu; Jie Ni; Qiulin Zhang; Jun Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Focal seizure as a manifestation of serotonin syndrome: case report.

Authors:  Eyad Almallouhi; Mohamad Rahwan; Helen Dainton; Leonardo Bonilha
Journal:  Avicenna J Med       Date:  2019 Jul-Sep

7.  Food-derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice.

Authors:  Noritaka Nakamichi; Keigo Nakayama; Takahiro Ishimoto; Yusuke Masuo; Tomohiko Wakayama; Hirotaka Sekiguchi; Keita Sutoh; Koji Usumi; Shoichi Iseki; Yukio Kato
Journal:  Brain Behav       Date:  2016-04-22       Impact factor: 2.708

Review 8.  Diet Versus Exercise in Weight Loss and Maintenance: Focus on Tryptophan.

Authors:  Barbara Strasser; Dietmar Fuchs
Journal:  Int J Tryptophan Res       Date:  2016-05-10

9.  Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.

Authors:  Gordon K Wilcock; Serge Gauthier; Giovanni B Frisoni; Jianping Jia; Jiri H Hardlund; Hans J Moebius; Peter Bentham; Karin A Kook; Bjoern O Schelter; Damon J Wischik; Charles S Davis; Roger T Staff; Vesna Vuksanovic; Trevor Ahearn; Luc Bracoud; Kohkan Shamsi; Ken Marek; John Seibyl; Gernot Riedel; John M D Storey; Charles R Harrington; Claude M Wischik
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Knowledge, Attitude, and Practice (KAP) Study on Serotonin Syndrome Among Neuro Physicians.

Authors:  Sanjay Prakash; Chaturbhuj Rathore; Kaushik Rana
Journal:  Ann Indian Acad Neurol       Date:  2020-02-07       Impact factor: 1.383
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.